Welcome to the The Proteomics News Network News Network
This News Network is designed to help people track and share news about The Proteomics News Network.
The Proteomics News Network
0
Clips
Reuters: Deals:
NEW YORK/PHILADELPHIA (Reuters) - Onyx Pharmaceuticals Inc said on Monday it has agreed to buy Proteolix Inc, a privately held biotechnology company developing cancer drugs, for an upfront cash payment of $276 million, sending its shares up more than 7 percent.
. (Read More)
Topics:
biotech,
Biotechnology
0
Clips
Reuters: Mergers News:
NEW YORK/PHILADELPHIA, Oct 12 (Reuters) - Onyx
Pharmaceuticals Inc said on Monday it has agreed to
buy Proteolix Inc, a privately held biotechnology company
developing cancer drugs, for an upfront cash payment of $276
million.
. (Read More)
Topics:
biotech,
Biotechnology
0
Clips
Health News from Medical News Today:
In an effort to educate the public about biotechnology, its numerous applications, and its most recent innovations, the Biotechnology Industry Organization (BIO) has created a series of educational web videos to answer many of the basic questions of biotech - "What is it?" "How does it affect me?" an. (Read More)
Topics:
biotech,
Biotechnology
0
Clips
Wired Science:
This year’s Nobel Prize in Chemistry went to three molecular biologists who study ribosomes, the protein factories within cells.Ribosomes were discovered in the 1950’s by George Palade, who went on to win the Nobel Prize in Physiology or Medicine for his work on the makeup of cells, but scientists weren’t able to take a clo (Read More)
0
Clips
Reuters: Mergers News:
PHILADELPHIA/NEW YORK, Oct 7 (Reuters) - Hype about the
swine flu vaccines, pent-up demand for cash and a push by major
drugmakers to boost their flagging research pipelines has
helped lift biotechnology fund-raising 36 percent so far this
year.
. (Read More)
Topics:
biotech,
Biotechnology
0
Clips
Health News from Medical News Today:
The Biotechnology Industry Organization (BIO) today announces future locations of the BIO International Convention. The Convention next heads to Chicago for the 2010 BIO International Convention, being held May 3-6 at McCormick Place. The Convention was last held in Chicago in 2006. "We are excited to bring the world's (Read More)
Topics:
biotech,
Biotechnology
0
Clips
Wall Street Journal:
FRANKFURT (MarketWatch) -- The Human Stem Cell Institute, a Russian biotechnology company, said Wednesday it hopes to raise as much as 165 million rubles (about $5.53 million) in its initial public offering on the Micex exchange in Moscow, becoming the first Russian company to launch an IPO this year. The offering will comp (Read More)
Topics:
biotech,
Biotechnology
0
Clips
Wired Science:
This year’s Nobel Prize in medicine went to a trio of scientists who discovered the enzyme telomerase, which allows cells to divide without any limits, making them effectively immortal.But if they used that trick on you, it would surely end your life. Coax cells into producing telomerase, and they will survive indefinitely, (Read More)
0
Clips
Wall Street Journal:
BOSTON (MarketWatch) -- Drug stocks were split in early trading Monday as shares of Seattle Genetics dived after the biotech group said it was halting a Phase II clinical trial for its lymphoma drug candidate dacetuzumab due to disappointing results. The NYSE Arca Pharmaceutical Index was down nominally at 282.46 while th (Read More)
Topics:
biotech,
Biotechnology
0
Clips
Health News from Medical News Today:
Laboratory and Battelle Fellow Dick Smith of the Department of Energy's Pacific Northwest National Laboratory has been recognized for his many accomplishments in pioneering the development of proteomics tools. Scientists use these instruments to study the array of proteins and related molecules that make up much of human bl (Read More)
Topics:
Proteomics
1
Clip
New York Times:
Google's new venture capital arm is making its first investment in biotechnology. It is putting money into Adimab, which has a novel method of generating protein-based drugs. (Read More)
Topics:
biotech,
Biotechnology
0
Clips
New York Times:
Google's new venture capital arm is making its first investment in biotechnology. It is putting money into Adimab, which has a novel method of generating protein-based drugs.
. (Read More)
Topics:
biotech,
Biotechnology
0
Clips
Reuters: Deals:
PARIS (Reuters) - Sanofi-Aventis has bought French biotechnology company Fovea, specialized in eye diseases, and expanded its cancer portfolio through an exclusive worldwide drug licensing deal with Merrimack Pharmaceuticals Inc.
. (Read More)
Topics:
biotech,
Biotechnology
0
Clips
Wall Street Journal:
Abbott Shells Out $7 Billion for SolvayGOOD MORNING. Stocks in Asia closed sharply lower today; U.S. futures are pointing to a higher open.Drug companies face some big headaches these days, from a wave of patent expirations to cutbacks in spending on prescription drugs. So what’s a beleaguered Big Pharma firm to do? Make an (Read More)
0
Clips
Wall Street Journal:
Health care is one of the most contentious issues of 2009. Nobody denies it’s a good idea to help the more than 40 million uninsured get coverage. The debate is over how to do it. The White House and Congress each have their own plans. And for months, there has been backroom brokering. It is still unclear what form a plan w (Read More)
Topics:
biotech,
Biotechnology
Add something
invite your friends to the "The Proteomics News Network" News Network
Info and Settings
Created by: Zen Brayn
Created on:
Nov 04, 2008
News Network Members (2)
Topics
Use the arrows to adjust the relevance rankings.
Sources
Use the arrows to adjust relevance rankings.
|
|||||
|
|
|||||
